Revenue, last quarter
$909K
+115.4% vs same quarter last year
Net income
−$2.9M
−0.6% vs same quarter last year
EPS, diluted
−$0.06
+25% vs same quarter last year
Operating cash flow
−$2.9M
−24.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$11.2M |
| FY24 | −$8.8M |
| FY23 | −$10.2M |
| FY22 | −$9.9M |
| FY21 | −$6.3M |
| FY20 | −$3.8M |
| FY19 | - |
News
No stories filed under RenovoRx yet - coverage appears here as the news feed clusters it.